Some populations are at a higher risk of developing severe coronavirus disease (COVID-19). The elderly, those who are immunocompromised, and those with underlying health conditions may experience severe symptoms at a heightened risk of death. As the pandemic evolved, more people are deemed at higher risk, including men and obese people.
Research conducted by the University of Valencia (UV) and the Jaume I University of Castellón (UJI), among other institutions, has found alterations to the structure of the brain's nonapeptidergic systems, social behavior and the production of pheromones, traits that reveal sexual dimorphism, in male mice with a lack of the Mecp2 gene.
In 2019, approximately 463 million people worldwide had diabetes, of which the vast majority (around 90%) was type 2 diabetes. Diabetes doubles the risk of coronary heart disease, stroke, and death from cardiovascular disease. Obesity is the main modifiable cause of type 2 diabetes, while genetic make-up may also identify individuals with a greater likelihood of developing the condition.
Women with Alzheimer’s disease tend to live longer than men with the disease — and a new study suggests that a gene on the X chromosome may help explain why.
Over the past few months, a number of drugs have been under investigation to treat COVID-19 without well-established safety or data to support these claims. However, some of these unproven therapies may have underlying genetic reasons for not being effective and resulting in fatal adverse effects as found with hydroxychloroquine.
In a new study from the Danish psychiatry project iPSYCH, researchers have identified genetic risk factors for developing bipolar disorder and psychoses among people with depression.
